Developing and conducting trainings for health care providers about uterine fibroids

Summary#

Introduction 1113-2026 would amend New York City’s Administrative Code. It would require the Department of Health and Mental Hygiene (DOHMH) to develop and conduct training for health care providers about uterine fibroids; the bill’s stated focus is diagnosis and treatment. The bill is not law: it was referred to committee on October 8, 2026.

  • Within one year after the local law takes effect, DOHMH’s commissioner must develop and conduct training in consultation with NYC Health + Hospitals and other relevant stakeholders and experts.
  • The training must cover evidence-based treatment options, disparities and implicit bias in diagnosis and treatment, and informed consent and fertility counseling before fibroid-related surgery for patients of reproductive age.
  • The commissioner must review the training materials yearly and update them as needed, and must conduct outreach to make city health care providers aware of the training.
  • At the request of the Health + Hospitals president, the commissioner may help incorporate the training into that corporation’s existing training programs.
  • Starting no later than one year after the law takes effect, DOHMH must report yearly on the training, material updates, and provider completion numbers, including totals by hospital or health system affiliation. Reports must go to the Mayor and Council Speaker and be posted online.

What it means for you#

  • Health care providers: DOHMH must make them aware of the training. The bill does not require providers to take or complete it.
  • DOHMH: The commissioner would have the duties to develop, conduct, review, update, promote, and report on the training.
  • Health + Hospitals: Its president may request help incorporating the training into existing programs. The bill does not require that corporation to make the request or add the training.
  • Patients: The bill does not create a new patient right or require providers to use a particular treatment. It requires the training to include specified guidance and topics.

Money#

No publicly available information.

  • The bill gives DOHMH new duties but provides no cost estimate, funding amount, or staffing plan.

What is unclear#

  • The bill does not define “health care provider” or say which providers the training is intended to cover.
  • It does not set rules for how training is delivered or how providers’ completion is verified.
  • The effective date would be immediate once the local law takes effect, but the bill is not yet law and its passage is uncertain.
  • The supplied materials do not include the current Administrative Code text, so the existing law and the exact change to it could not be checked.

Case for#

  • The bill’s required topics address treatment options, informed consent, and disparities and implicit bias. A possible argument for the bill is that shared training on these subjects could support more informed care for patients with fibroids.

Case against#

  • The bill requires DOHMH to develop, conduct, promote, and report on training, but does not specify resources or delivery methods. One concern is that the duties and costs may be hard to assess from the text.
  • The bill does not require providers to complete the training, so its reach may depend on how providers respond to the outreach.